Skip to main content
. Author manuscript; available in PMC: 2012 Nov 30.
Published in final edited form as: Menopause. 2011 Nov;18(11):1172–1177. doi: 10.1097/gme.0b013e31821b01c7

FIG. 2.

FIG. 2

T scores in relation to years of not using HT since 2002. Note the mean BMD T-scores by cumulative years of HT nonuse before the year of DXA scan in 54,209 women. The linear regression model was adjusted for age, race, BMI, bisphosphonate use at the time of DXA scan, and year of DXA scan. HT, hormone therapy; BMD, bone mineral density; DXA, dual-energy x-ray absorptiometry; BMI, body mass index.